Related Experiment Video
Updated: Nov 3, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Approach to Pediatric Intractable Migraine
Mohammed Alqahtani1, Rebecca Barmherzig2, Ana Marissa Lagman-Bartolome3,4
1Division of Neurology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.
Insights
Intractable migraine in children significantly impacts quality of life. This review outlines a comprehensive management approach, including acute and preventive therapies for pediatric intractable migraine.
Area of Science:
- Pediatric Neurology
- Headache Medicine
- Quality of Life Research
Background:
- Intractable migraine in children and adolescents causes significant disability and reduced quality of life (QoL).
- Current management strategies often rely on adult data or expert consensus due to limited pediatric-specific research.
- A lack of a unifying definition for intractable migraine complicates diagnosis and treatment.
Purpose of the Study:
- To review current best-practice approaches for evaluating and managing intractable migraine in pediatric populations.
- To present evidence-based and consensus-driven strategies for acute and preventive therapy.
- To highlight the importance of a comprehensive approach including diagnosis, risk factor management, and adaptive coping strategies.
Main Methods:
- Descriptive review of available literature on pediatric intractable migraine management.
- Focus on outpatient, emergency department (ED), and inpatient treatment strategies.
- Consideration of clinical data, safety, tolerability, cost-effectiveness, and expert consensus.
Main Results:
- A comprehensive approach involves excluding secondary causes, accurate diagnosis, managing modifiable risk factors, and initiating pharmacologic therapy.
- Management strategies include acute medications, bridge therapy, emerging preventive therapies, and stepwise combination therapy.
- Treatment aims to reduce disability, improve QoL, prevent progression, and develop pain coping strategies.
Conclusions:
- Effective management of pediatric intractable migraine requires a multidisciplinary and stepwise approach.
- Evidence-based strategies and expert consensus guide the treatment of acute and preventive aspects of this condition.
- Optimizing treatment can significantly improve outcomes and quality of life for affected children and adolescents.
Purpose Of Review:
Intractable migraine in children and adolescents is a significant cause of disability and decreased quality of life (QoL) in this population. Challenges include lack of unifying definition for intractable migraine, and limited data on best-practice management in this age group, with most current treatment pathways extrapolated from adult studies or expert consensus.
Recent Findings:
A comprehensive approach in the evaluation and management of intractable migraine in this age group encompasses excluding secondary causes of headache; making an accurate diagnosis; identifying and appropriately managing modifiable risk factors; and initiating appropriate pharmacologic therapy to reduce disability, improve health-related quality of life, reduce risk of progression, and develop adaptive pain coping strategies. Several strategies for management of pediatric intractable migraine including use of acute medications, bridge therapy in outpatient setting, emerging therapies for preventive therapy, and a stepwise combination therapy for management of pediatric intractable migraine in emergency and inpatient setting are presented based on available clinical data, safety/tolerability, availability, cost-effectiveness, and expert consensus. This descriptive review of the available literature focuses on approach to therapy for acute intractable migraine in a pediatric population including outpatient, emergency department (ED), and inpatient management.
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

